Abstract:Objective To explore the occurrence and influencing factors of recurrent chronic limb-threatening ischemia (CLTI)-related events in elderly patients with lower extremity arteriosclerosis obliterans (LEASO) after percutaneous transluminal angioplasty (PTA). Methods A total of 150 elderly LEASO patients admitted to Beijing Rehabilitation Hospital, Capital Medical University from January 2022 to January 2024 were selected as study subjects, and they all underwent PTA. The success rate of surgery was recorded, and patients with successful surgery were followed up for 1 year. The incidence of CLTI-related events were statistically analyzed during follow-up, including unrelieved symptoms (presence of impaired wound healing and/or ischemic pain), lumen stenosis in the stent or 5 mm at both ends of the stent > 50%, and ipsilateral amputation. Data analysis was performed by SPSS 25.0. According to the data type, t test or Chi-square test was conducted for comparison between groups. Multivariate binary logistic regression(stepwise forward regression) model was utilized to analyze the factors influencing the occurrence of CLTI-related events in elderly LEASO patients at 1 year after PTA. Results Among the 150 LEASO patients who underwent PTA, the overall success rate of surgery was 94.67% (142/150), specifically, 97.56% (40/41) for iliac artery lesions, 90.52% (105/116) for femoropopliteal artery lesions, and 90.77% (59/65) for infrapopliteal artery lesions. According to Trans-Atlantic Inter-Society Consensus (TASC) Ⅱ classification, the success rate was 94.94% (75/79), 92.86% (65/70), 87.80% (36/41), and 87.50% (28/32) for type A, B, C, and D lesions, respectively. There was no statistically significant difference in PTA success rate among different TASCⅡ types (χ2=2.818, P=0.421). During 1-year follow-up, among the 142 patients with successful PTA, 53 (37.32%) had CLTI-related events, including 13 (13/53,24.53%) with unrelieved symptoms, 39 (39/53,73.58%) with lumen stenosis in the stent or 5 mm at both ends of the stent > 50%, and 1 (1/53,1.89%) with ipsilateral amputation. The 53 patients with CLTI-related events were assigned to the CLTI positive group, and the 89 patients without CLTI-related events were assigned to the negative group. Multivariate binary logistic stepwise forward regression analysis suggested that TASCⅡ type C (OR=1.680,95%CI 1.331-2.122), type D (OR=2.008,95%CI 1.538-2.621), number of stents implanted ≥ 3 (OR=2.232,95%CI 1.171-4.254), preoperative glycosylated hemoglobin Alc (OR=2.442,95%CI 1.444-4.130), low-density lipoprotein cholesterol (OR=2.787,95%CI 1.147-6.773), and systemic immune inflammation index (OR=3.300,95%CI 1.611-6.762) were risk factors for CLTI-related events in elderly LEASO patients after PTA (P<0.05). Conclusion The overall success rate of PTA is high in elderly LEASO patients, but the incidence rates of CLTI-related events remain at high levels at 1 year after surgery. The occurrence of CLTI-related events after PTA is influenced by multiple factors. It is recommended to develop individualized surgical regimen in clinical practice, to apply drug-coated stents and anti-proliferative drugs for patients with excessive stents to enhance blood glucose and blood lipid control, and to strengthen the postoperative follow-up and screening in patients with high levels of body′s inflammation to enhance the prognosis of patients.